Efficacy and QOL of switching from insulin glargine U100 or insulin deglidec to insulin glargine U300 in type2 diabetes mellitus

Trial Profile

Efficacy and QOL of switching from insulin glargine U100 or insulin deglidec to insulin glargine U300 in type2 diabetes mellitus

Recruiting
Phase of Trial: Phase II

Latest Information Update: 01 Feb 2018

At a glance

  • Drugs Insulin degludec (Primary) ; Insulin glargine (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Most Recent Events

    • 01 Feb 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top